A phase II pilot study of sequential chemo-immunotherapy with capecitabina+ interferon α2A (IFN) followed by interleukina-2 (IL-2) in patients with metastatic renal cell carcinoma (MRCC): on behalf of the Gruppo Oncologico Nord Ovest (G.O.N.O.)
2006
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI